- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01695278
A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community (C4C)
19 november 2014 uppdaterad av: Mercedes Carnethon, Northwestern University
Coaching for Control: A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community
Diabetes poses a substantial burden to racial/ethnic minorities and in populations with limited access to healthcare.
However, there is a shortage of healthcare providers available to help patients adopt the lifestyle changes required for diabetes control.
The goal of the present study is to evaluate the feasibility and effectiveness of a diabetes self-care intervention delivered by medical students to patients with poorly controlled diabetes.
Training medical students to use proven communication techniques to help patients identify and overcome barriers to adopting lifestyle changes in diabetes is a novel but plausible strategy.
The investigators anticipate that findings from our pilot study will be used to develop a larger study to definitively test the program's effectiveness.
A long-term benefit of our program is that future healthcare providers are practicing the skills needed to promote positive lifestyle changes and provide care for chronic conditions in diverse communities.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Diabetes and its complications pose a substantial physical, psychological and financial burden on the large number of racial/ethnic minorities and other socioeconomically deprived persons with diabetes.
However, self-management goals are often not met in racial/ethnic minorities and in populations with fewer socioeconomic resources.
In response, our research team has developed a novel "health coaching" intervention to promote diabetes self-management in the community.
Health coaching is based on Control Systems Theory and helps patients to: 1) identify problems in self-care behaviors; 2) create dynamic plans for correcting these issues; and, 3) learn to navigate the complexities of everyday life and to achieve clinically and personally desirable outcomes.
The primary innovation of the present project is that first-year medical students are trained to serve as the health coaches, and are participating in the study Coaching for Control (STU00069506).
The objective of our pilot study is to test whether 20 patients from five Northwestern Medicine primary care practice groups (two in the Austin community, two at Northwestern Memorial Hospital and one at Norwegian American Hospital) enrolled in the "Coaching for Control" intervention experience favorable changes in clinical and behavioral outcomes after 16 weeks as compared with an equal number of patients from those same clinics who are not enrolled in the program.
We will use a non-randomized trial design to carry out the following aims: 1. Determine whether patients with diabetes who participate in the "Coaching for Control" behavioral intervention program (i.e., the intervention arm) have lower hemoglobin A1c (HbA1c) after four months than patients who do not participate in the program (i.e., the control arm).
2. Determine whether diabetes patients in the intervention arm report higher task-related self-efficacy for initiating and maintaining recommended diabetes self-care behaviors than participants in the control arm.
We hypothesize that participants in the intervention arm will have more favorable HbA1c and report higher self-efficacy for diabetes self-care behaviors than participants in the control arm.
Secondary objectives are to test whether these changes persist 8 months after the program ends and to test whether we observe changes in additional clinical measures such as blood pressure, waist circumference, and in self-reported health behaviors such as medication adherence, self-care behaviors, physical activity and diet.
Process evaluations through focus groups and interviews with participants will allow us to refine our intervention.
The translational aspects of our proposal include the application of a proven intervention to promote diabetes self-care in a community setting that includes adults at high risk for diabetes complications.
Findings from the present pilot study will be used to justify expansion of the study to a larger group of community members so that we can carry out a larger randomized trial of efficacy.
Studietyp
Interventionell
Inskrivning (Faktisk)
16
Fas
- Fas 3
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60611
- Northwestern University
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- age > 18 years old,
- diagnosis of diabetes
- ability to read and understand English,
- access to a personal telephone,
- intent to remain in the medical practice group for at least 1 year,
- intention to remain in the Chicago, IL area or surrounding suburbs for 1 year.
- Ability to read and understand the informed consent.
Exclusion Criteria:
- primary diagnosis of gestational diabetes or type 1 diabetes
- severe mental impairment,
- primary preferred language other than English
- severe comorbidity with a life expectancy of < 1 year
- currently enrolled in another counseling-based diabetes intervention program
- prior participation in the Coaching for Control intervention development in 2012
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Standard Care
Participants will receive standard care from physicians for monitoring and treating their diabetes.
They are placed on a wait list to receive the intervention.
|
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Experimentell: Telephone Counseling
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in hemoglobin A1c
Tidsram: 16 weeks
|
Changes in hemoglobin A1c between baseline and the end of follow-up will be compared between participants in the intervention arm vs. the control arm.
|
16 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Task related self-efficacy for initiating and maintaining diabetes self-management
Tidsram: 16 weeks
|
Determine whether diabetes patients in the intervention arm report higher task-related self-efficacy for initiating and maintaining recommended diabetes self-care behaviors than participants in the wait list control arm.
|
16 weeks
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Diabetes self-management behaviors
Tidsram: 16 weeks
|
To describe differences in diabetes self-management behavior in participants in the intervention as compared with the wait list control arm
|
16 weeks
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Mercedes R Carnethon, PhD, Northwestern University
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 september 2012
Primärt slutförande (Faktisk)
1 januari 2014
Avslutad studie (Faktisk)
1 augusti 2014
Studieregistreringsdatum
Först inskickad
24 september 2012
Först inskickad som uppfyllde QC-kriterierna
26 september 2012
Första postat (Uppskatta)
27 september 2012
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
21 november 2014
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
19 november 2014
Senast verifierad
1 november 2014
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- STU00068025
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Diabetes mellitus, typ 2
-
Mathias Ried-LarsenOkändDiabetes mellitus, typ 2 | Typ 2-diabetes mellitus | Diabetes typ 2 | Typ 2 diabetes mellitusDanmark
-
SanofiAvslutadTyp 1-diabetes mellitus-typ 2-diabetes mellitusUngern, Ryska Federationen, Tyskland, Polen, Japan, Förenta staterna, Finland
-
Hanmi Pharmaceutical Company LimitedOkändTyp 2 diabetes mellitus | Typ 1 diabetes mellitusFörenta staterna
-
Caroline M KistorpRigshospitalet, Denmark; Herlev and Gentofte Hospital; Danish Heart FoundationAvslutadTyp 2 diabetes mellitusDanmark
-
TheracosAvslutadTyp 2 diabetes mellitusFörenta staterna
-
Biocon LimitedAvslutadJämförelse av insulin tregopil (IN-105) med insulin aspart hos patienter med typ 2-diabetes mellitusTyp 2 diabetes mellitusIndien
-
Chong Kun Dang PharmaceuticalOkändTyp 2 diabetes mellitusKorea, Republiken av
-
PegBio Co., Ltd.AvslutadTyp 2 diabetes mellitusKina
-
Chong Kun Dang PharmaceuticalAvslutadTyp 2 diabetes mellitusKorea, Republiken av
-
Daiichi Sankyo Co., Ltd.AvslutadTyp 2 diabetes mellitusJapan
Kliniska prövningar på Telephone Counseling
-
International Rescue CommitteeGeorge Washington University; World Health OrganizationHar inte rekryterat ännuVåld i intim partner
-
Northwestern UniversityGeorgetown UniversityAnmälan via inbjudanKroniska njursjukdomar | Genetisk predispositionFörenta staterna
-
University of California, BerkeleyNational Institute of Mental Health (NIMH); Ministry of Health, Tanzania; Management and Development for Health och andra samarbetspartnersRekrytering
-
The University of Tennessee, KnoxvilleColorado State UniversityAktiv, inte rekryterandeCannabisanvändningsstörning, mild | Cannabisanvändningsstörning, måttlig | Störning av cannabisanvändning, allvarligFörenta staterna
-
University of PennsylvaniaAbramson Cancer Center of the University of PennsylvaniaAvslutad
-
Temple UniversityOkändStillasittande livsstil | CigarettrökningFörenta staterna
-
University of PittsburghHar inte rekryterat ännuTransforaminal Lumbal Interbody Fusion | Anterior cervikal diskektomi och fusionFörenta staterna
-
Fangbiao TaoHar inte rekryterat ännuPerinatal depression | Stegvis vård
-
Yale UniversityAvslutad
-
University of California, BerkeleyNational Institute of Mental Health (NIMH); Ministry of Health and Social...Avslutad